Breaking the gene barrier in schizophrenia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

14 citing papers in PubMed.

1. Trajectories of working memory and decision making abilities along juvenile development in mice.Frontiers in neuroscience · 2025
   Article
2. Development of Prefrontal Circuits and Cognitive Abilities.Cold Spring Harbor perspectives in biology · 2024
   Review
3. P50, N100, and P200 Auditory Sensory Gating Deficits in Schizophrenia Patients.Frontiers in psychiatry · 2020
   Article
4. Auditory Event-Related Potentials in Antipsychotic-Free Subjects With Ultra-High-Risk State and First-Episode Psychosis.Frontiers in psychiatry · 2019
   Article
5. Schizophrenia as a disorder of molecular pathways.Biological psychiatry · 2015
   Review
6. Neurodevelopment, GABA system dysfunction, and schizophrenia.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2015
   Review
7. Modulation of behavioral networks by selective interneuronal inactivation.Molecular psychiatry · 2014
   Article
8. The role of cannabinoid 1 receptor expressing interneurons in behavior.Neurobiology of disease · 2014
   Article
9. Immune system disturbances in schizophrenia.Biological psychiatry · 2014
   Review
10. Is lead exposure in early life an environmental risk factor for Schizophrenia? Neurobiological connections and testable hypotheses.Neurotoxicology · 2012
    Review
11. Gene expression profiling of the brain: pondering facts and fiction.Neurobiology of disease · 2012
    Review
12. Synaptic changes in the brain of subjects with schizophrenia.International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience · 2011
    Review
13. Analyzing schizophrenia by DNA microarrays.Biological psychiatry · 2011
    Review
14. Gene expression profiling in rodent models for schizophrenia.Current neuropharmacology · 2010
    Article

Corrections and comments

• Comment on
  A primate-specific, brain isoform of KCNH2 affects cortical physiology, cognition, neuronal repolarization and risk of schizophrenia.2009

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as